Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
10/2003
10/30/2003US20030203909 A N-phenyl-benzo(b)thiophene-carboxamide derivatives, as enzyme inhibitor of tyrosine kinase; antiproliferation of lymphocyte, treating autoimmune disease, rheumatic disease, as immunosuppressant, antiinflammatory agents
10/30/2003US20030203906 Novel substituted diamine derivatives useful as motlin antagonists
10/30/2003US20030203902 A 2-hydroxy-2-trifluoromethyl-valeroylamino benzotriazole, or benzo(1,2,5)thiadiazole, or benzo(1,2,5)oxadiazole derivatives; contraceptive agents, for treating endometriosis, gynecological disorders, male birth control
10/30/2003US20030203900 An inhibitors against Cathepsin enzyme, 4-oxo-tetrahydrofuran-3s-ylcarbamoyl derivatives, for treating degenerative diseases
10/30/2003CA2483227A1 Antiviral inhibition of capsid proteins
10/30/2003CA2482715A1 Antiviral lactone-ureas
10/30/2003CA2482510A1 Monotherapy for the treatment of parkinson`s disease with cyclooxygenase-2 (cox 2) inhibitor(s)
10/29/2003EP1357104A1 Tropolone derivative
10/29/2003EP1355956A2 Polymerization of olefinic compounds
10/29/2003EP1355897A1 Process for the preparation of 1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile
10/29/2003EP1355648A2 1,2-DISUBSTITUTED CYCLIC INHIBITORS OF MATRIX METALLORPROTEASES AND TNF-$g(a)
10/29/2003EP1204663B1 Novel spiro compounds with neuropeptide y antagonistic activity
10/29/2003EP1140047B1 Endocrine therapy for breast cancer: combined treatment with tamoxifen plus alkyl pcdfs
10/29/2003EP1091952B1 Thiophene and furan 2,5-dicarboxamides useful in the treatment of cancer
10/29/2003EP1089964B1 Hydrazine derivatives
10/29/2003EP1016660B1 Compounds having 2.2.1]bicyclo skeleton
10/29/2003EP0923566B1 High molecular weight polymer-based prodrugs
10/28/2003US6639067 Continuous process for the production of anhydrosugar alcohols
10/28/2003US6638980 Inhibitors of factor Xa
10/28/2003US6638979 Imidamide derivatives
10/28/2003US6638972 Chroman and benzofuran derivatives as 5-hydroxytryptamine-6 ligands
10/28/2003US6638967 Pyrrole, furan, thiofuran and phenyl derivatives; inhibition of histamine H3 receptor activity; for example, 1-((4-(4-Pyrrolidin-1-ylmethyl-phenyl)-thien-2-yl)methyl)-pyrrolidine
10/28/2003US6638947 Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof
10/28/2003US6638936 Treatment of obesity in mammals, comprising administering to mammal in need of such treatment, treatment of obsessive compulsive disorder in mammals, comprising administering to a mammal treatment of depression in mammals
10/28/2003US6638931 Aminoguanidines and alkoxyguanidines as protease inhibitors
10/28/2003US6638927 Melanocortin-4 receptor (MC4-R) agonists; treating obesity or diabetes; 4-((N-cyclohexyl-3,5-dimethyl-piperazine-1-carboximidoyl)-amino)-N-(2-(2,4 -dichlorophenyl) -ethyl)-benzamide for example
10/23/2003WO2003087085A1 Heterocyclic amide derivatives as cytokine inhibitors
10/23/2003WO2003087084A1 3-aminophenol derivatives and dyes that contain these compounds while serving to dye keratin fibers
10/23/2003WO2003087081A1 Process and intermediates for preparing escitalopram
10/23/2003WO2003087080A1 Medicinal composition for improving angiotension-regulating function of blood vessel endothelium
10/23/2003WO2003087062A2 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation
10/23/2003WO2003087057A1 Benzamide derivatives useful as histone deacetylase inhibitors
10/23/2003WO2003087037A1 Substituted aryl amides
10/23/2003WO2003087035A1 2,5-bis-diamine-'1,4! benzoquinone derivatives for the treatment of alzheimer's disease a process for their preparation and intermediates therefor
10/23/2003WO2003087034A1 3-aminophenol derivatives substituted in the 2-position, and dyes containing these compounds
10/23/2003WO2003086385A1 Derivatives of 1-(oxoaminoacetyl) pentylcarbamate as cathepsin k inhibitors for the treatment of bone loss
10/23/2003WO2003086288A2 Bicyclic amides
10/23/2003WO2003086287A2 Compounds and methods for inducing apoptosis in proliferating cells
10/23/2003WO2003055848A3 Urea derivatives as vr1- antagonists
10/23/2003WO2003007872A3 Process for the preparation of citalopram hydrobromide
10/23/2003US20030199708 Process for the preparation of cyclic diketones
10/23/2003US20030199578 Naphthalene amides as potassium channel openers
10/23/2003US20030199575 P-hydroxyphenyl propionic acid derivatives as antiproliferative agents
10/23/2003US20030199572 Use as pesticides and herbicides
10/23/2003US20030199563 Heterocyclic containing biphenyl aP2 inhibitors and method
10/23/2003US20030199561 Boronic ester and acid compounds, synthesis and uses
10/23/2003US20030199521 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (BVDV) infection and hepatitis C virus (HCV) infection
10/23/2003US20030199510 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity
10/23/2003US20030199500 Tetrahydrofuran derivatives and their use as nk-1 antagonists
10/23/2003US20030199499 Novel guanidinobenzamides
10/23/2003US20030199493 A dibenzofuranazepine derivatives for use as therapeutic treatment of Alzheimer's disease, Parkinson's disease, Huntington's disease, multiple sclerosis, amyotrophic lateral sclerosis, epilepsy, stroke, cerebral trauma
10/23/2003US20030199482 Anticholesterol agents; a drug mixture for treating hypercholesterolemia comprising an apical sodium co-dependent bile acid transport inhibitor, enzyme inhibitors of a cyclooxygenase-2
10/23/2003DE19983836C1 Verfahren zur Herstellung von Citalopram, 4-[1-(4- Fluorphenyl)-methanoyl]-benzonitril-Derivate und Verfahren zu deren Herstellung und deren Verwendung A process for the preparation of citalopram, 4- [1- (4-fluorophenyl) -methanoyl] -benzonitrile derivatives and process for their preparation and their use
10/23/2003CA2485679A1 Compounds and methods for inducing apoptosis in proliferating cells
10/23/2003CA2482703A1 Medicinal composition for improving angiotension-regulating function of blood vessel endothelium
10/23/2003CA2482391A1 2,5-bis-diamine-'1,4! benzoquinone derivatives for the treatment of alzheimer's disease a process for their preparation and intermediates therefor
10/23/2003CA2481313A1 Bicyclic amides
10/23/2003CA2480856A1 Substituted aryl amides
10/22/2003EP1354887A1 Ligands for metals and improved metal-catalyzed processes based thereon
10/22/2003EP1354881A1 Process for the preparation of 3-methyltetrahydrofuran
10/22/2003EP1353898A2 Compounds to treat alzheimer's disease
10/22/2003EP1353662A2 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
10/22/2003EP1254129B1 Method for the preparation of 5-cyanophthalide
10/22/2003EP1183236B1 Cinnamoylaminoalkyl-substituted benzenesulfonamide derivatives
10/22/2003EP1159276B1 Benzofuran-2-ones as colorants for organic materials
10/22/2003EP1032566B9 Method for the preparation of citalopram
10/22/2003CN1450999A Novel piperazine derivatives
10/22/2003CN1450991A Hydroxamate derives useful as deacetylase inhibitors
10/22/2003CN1450989A 7-substituted tetracycline compounds
10/22/2003CN1450059A Medicinal compound with anti-infection, anti-inflammatory and antipyretic, and improving immunity function
10/22/2003CN1450047A Process for preparation of cyclic diketones
10/22/2003CN1125067C Crystalline antifungal polymorph
10/22/2003CN1125062C Dihydrobenzofuran and related compounds useful useful as anti-inflammatory agents
10/22/2003CN1125044C Novel prostaglandin synthase inhibitors
10/22/2003CN1125026C Process for preparing gamma-butyrolactone butane-1,4-diol and tetrahydrofuran
10/21/2003US6635773 Purification by selective extraction of citalopram or its impurities using organic solvents and water, and the process for preparing citalopram salts
10/21/2003US6635673 1-Aminomethyl-3,4-dimethyl-cyclopentyl acetic acid; epilepsy; neurodegenerative, neuropathological and gastrointestinal disorders; depression, anxiety, panic, pain
10/21/2003US6635672 Agent for lowering prolactin
10/21/2003US6635668 Imidazoline receptor binding compounds
10/21/2003US6635655 Agonists or antagonists of peroxisome proliferator-activated receptors
10/21/2003US6635650 Such as N-(2-(7-(2-((8-(2-(acetyl-amino)ethyl)-2-naphthyl) oxy)ethoxy)-1-napthyl)ethyl)acetamide for treating or preventing melatoninergic disorders
10/21/2003US6635631 Iron compounds, compositions, methods of making the same and uses thereof
10/21/2003CA2153979C Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents
10/21/2003CA2003480C Fungicides
10/16/2003WO2003084927A1 Haloalkenes, process for production thereof, and pest controllers containing the same
10/16/2003WO2003084916A2 Compounds that modulate ppar activity and methods for their preparation
10/16/2003WO2003084610A1 Therapy for psychoses combining an atypical antipsychotic and an mglu2/3 receptor agonist
10/16/2003WO2003084537A1 Therapeutic agent for food competence disorder in stomach
10/16/2003WO2003039231A3 Compounds and methods for treating transplant rejection
10/16/2003WO2002100849A3 Novel nitriles useful as reversible inhibitors of cysteine proteases
10/16/2003WO2002100347A3 Prodrugs of gaba analogs, compositions and uses thereof
10/16/2003WO2002076939A3 Cysteine protease inhibitors
10/16/2003WO2002059084A3 Inhibitors of adp-ribosyl transferases, cyclases, and hydrolases, and uses thereof
10/16/2003WO2001066534A3 Cyclic and bicyclic diamino histamine-3 receptor antagonists
10/16/2003US20030195362 For therapy of retroviral infection and in particular an HIV infection
10/16/2003US20030195354 For use as fungicide
10/16/2003US20030195352 For therapy of diabetes, obesity, impaired glucose tolerance, gastrointestinal disorders, hypertriglyceridemia, hypercholesteolemia, atherosclerotic disorders, or cardiovascular disorders
10/16/2003US20030195258 Taxol enhancer compounds
10/16/2003US20030195247 Antagonists of protein tryosin phosphatase 1B (PTP-1B) and T-cell protein tyrosine phosphatase (TC-PTP), used as antidiabetic agents and for prophylaxis of insulin resistance
10/16/2003US20030195246 Seamless soft capsule preparations containing dihydrobenzofuran derivatives
1 ... 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 ... 472